Chimeric Infectious Bursal Disease Virus-Like Particles as Potent Vaccines for Eradication of Established HPV-16 E7–Dependent Tumors

Virus‑like particles as a vaccine delivery system: Myths and facts

(2011) Polly Roy et al.   Human vaccines & immunotherapeutics

Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway

(2011) Stephanie J Win et al.   IMMUNOLOGY AND CELL BIOLOGY

Hepatitis B surface antigen fusions delivered by DNA vaccination elicit CTL responses to human papillomavirus oncoproteins associated with tumor protection

(2010) O Haigh et al.   CANCER GENE THERAPY

Strategies for Cancer Vaccine Development

(2010) Matteo Vergati et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Cancer Immunotherapy and Nanomedicine

(2010) Wei-Yun Sheng et al.   PHARMACEUTICAL RESEARCH

Tumor immunogenicity and responsiveness to cancer vaccine therapy: The state of the art

(2010) Taylor H. Schreiber et al.   SEMINARS IN IMMUNOLOGY

Adjuvants for cancer vaccines

(2010) Thomas W. Dubensky et al.   SEMINARS IN IMMUNOLOGY

Follicular and Marginal Zone B Cells Fail to Cross-Present MHC Class I-Restricted Epitopes Derived from Viral Particles

(2009) Susanne A. Keller et al.   JOURNAL OF IMMUNOLOGY

The capsid protein of infectious bursal disease virus contains a functional α4β1 integrin ligand motif

(2009) Laura Delgui et al.   VIROLOGY